192 related articles for article (PubMed ID: 17581121)
21. Mechanism-based inhibitors of the aspartyl protease plasmepsin II as potential antimalarial agents.
Gupta D; Yedidi RS; Varghese S; Kovari LC; Woster PM
J Med Chem; 2010 May; 53(10):4234-47. PubMed ID: 20438064
[TBL] [Abstract][Full Text] [Related]
22. Molecular characterization and inhibition of a Plasmodium falciparum aspartic hemoglobinase.
Francis SE; Gluzman IY; Oksman A; Knickerbocker A; Mueller R; Bryant ML; Sherman DR; Russell DG; Goldberg DE
EMBO J; 1994 Jan; 13(2):306-17. PubMed ID: 8313875
[TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of plasmepsin I and plasmepsin II inhibitors with activity in Plasmodium falciparum-infected cultured human erythrocytes.
Nöteberg D; Hamelink E; Hultén J; Wahlgren M; Vrang L; Samuelsson B; Hallberg A
J Med Chem; 2003 Feb; 46(5):734-46. PubMed ID: 12593654
[TBL] [Abstract][Full Text] [Related]
24. Food vacuole plasmepsins are processed at a conserved site by an acidic convertase activity in Plasmodium falciparum.
Banerjee R; Francis SE; Goldberg DE
Mol Biochem Parasitol; 2003 Jul; 129(2):157-65. PubMed ID: 12850260
[TBL] [Abstract][Full Text] [Related]
25. Quantitative pH measurements in Plasmodium falciparum-infected erythrocytes using pHluorin.
Kuhn Y; Rohrbach P; Lanzer M
Cell Microbiol; 2007 Apr; 9(4):1004-13. PubMed ID: 17381432
[TBL] [Abstract][Full Text] [Related]
26. Digestive-vacuole genesis and endocytic processes in the early intraerythrocytic stages of Plasmodium falciparum.
Abu Bakar N; Klonis N; Hanssen E; Chan C; Tilley L
J Cell Sci; 2010 Feb; 123(Pt 3):441-50. PubMed ID: 20067995
[TBL] [Abstract][Full Text] [Related]
27. Food vacuole targeting and trafficking of falcipain-2, an important cysteine protease of human malaria parasite Plasmodium falciparum.
Dasaradhi PV; Korde R; Thompson JK; Tanwar C; Nag TC; Chauhan VS; Cowman AF; Mohmmed A; Malhotra P
Mol Biochem Parasitol; 2007 Nov; 156(1):12-23. PubMed ID: 17698213
[TBL] [Abstract][Full Text] [Related]
28. The activity and inhibition of the food vacuole plasmepsin from the rodent malaria parasite Plasmodium chabaudi.
Martins TM; Domingos A; Berry C; Wyatt DM
Acta Trop; 2006 Feb; 97(2):212-8. PubMed ID: 16329985
[TBL] [Abstract][Full Text] [Related]
29. Spinning disk confocal microscopy of live, intraerythrocytic malarial parasites. 2. Altered vacuolar volume regulation in drug resistant malaria.
Gligorijevic B; Bennett T; McAllister R; Urbach JS; Roepe PD
Biochemistry; 2006 Oct; 45(41):12411-23. PubMed ID: 17029397
[TBL] [Abstract][Full Text] [Related]
30. Recombinant plasmepsin 1 from the human malaria parasite plasmodium falciparum: enzymatic characterization, active site inhibitor design, and structural analysis.
Liu P; Marzahn MR; Robbins AH; Gutiérrez-de-Terán H; Rodríguez D; McClung SH; Stevens SM; Yowell CA; Dame JB; McKenna R; Dunn BM
Biochemistry; 2009 May; 48(19):4086-99. PubMed ID: 19271776
[TBL] [Abstract][Full Text] [Related]
31. Plasmepsins as potential targets for new antimalarial therapy.
Ersmark K; Samuelsson B; Hallberg A
Med Res Rev; 2006 Sep; 26(5):626-66. PubMed ID: 16838300
[TBL] [Abstract][Full Text] [Related]
32. Predicting functional residues in Plasmodium falciparum plasmepsins by combining sequence and structural analysis with molecular dynamics simulations.
Valiente PA; Batista PR; Pupo A; Pons T; Valencia A; Pascutti PG
Proteins; 2008 Nov; 73(2):440-57. PubMed ID: 18442137
[TBL] [Abstract][Full Text] [Related]
33. Biosynthesis and maturation of the malaria aspartic hemoglobinases plasmepsins I and II.
Francis SE; Banerjee R; Goldberg DE
J Biol Chem; 1997 Jun; 272(23):14961-8. PubMed ID: 9169469
[TBL] [Abstract][Full Text] [Related]
34. Active-site specificity of digestive aspartic peptidases from the four species of Plasmodium that infect humans using chromogenic combinatorial peptide libraries.
Beyer BB; Johnson JV; Chung AY; Li T; Madabushi A; Agbandje-McKenna M; McKenna R; Dame JB; Dunn BM
Biochemistry; 2005 Feb; 44(6):1768-79. PubMed ID: 15697202
[TBL] [Abstract][Full Text] [Related]
35. Characterization of plasmepsin V, a membrane-bound aspartic protease homolog in the endoplasmic reticulum of Plasmodium falciparum.
Klemba M; Goldberg DE
Mol Biochem Parasitol; 2005 Oct; 143(2):183-91. PubMed ID: 16024107
[TBL] [Abstract][Full Text] [Related]
36. Functional profiling, identification, and inhibition of plasmepsins in intraerythrocytic malaria parasites.
Liu K; Shi H; Xiao H; Chong AG; Bi X; Chang YT; Tan KS; Yada RY; Yao SQ
Angew Chem Int Ed Engl; 2009; 48(44):8293-7. PubMed ID: 19784986
[No Abstract] [Full Text] [Related]
37. Synthesis, antimalarial evaluation and molecular modeling studies of hydroxyethylpiperazines, potential aspartyl protease inhibitors, part 2.
Cunico W; Gomes CR; Facchinetti V; Moreth M; Penido C; Henriques MG; Varotti FP; Krettli LG; Krettli AU; da Silva FS; Caffarena ER; de Magalhães CS
Eur J Med Chem; 2009 Sep; 44(9):3816-20. PubMed ID: 19403210
[TBL] [Abstract][Full Text] [Related]
38. Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors.
Parikh S; Gut J; Istvan E; Goldberg DE; Havlir DV; Rosenthal PJ
Antimicrob Agents Chemother; 2005 Jul; 49(7):2983-5. PubMed ID: 15980379
[TBL] [Abstract][Full Text] [Related]
39. Antimalarial activity of HIV-1 protease inhibitor in chromone series.
Lerdsirisuk P; Maicheen C; Ungwitayatorn J
Bioorg Chem; 2014 Dec; 57():142-147. PubMed ID: 25462990
[TBL] [Abstract][Full Text] [Related]
40. Exploring the flap pocket of the antimalarial target plasmepsin II: the "55 % rule" applied to enzymes.
Zürcher M; Gottschalk T; Meyer S; Bur D; Diederich F
ChemMedChem; 2008 Feb; 3(2):237-40. PubMed ID: 17918177
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
